Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

102.02
Delayed Data
As of Jan 17
 -2.80 / -2.67%
Today’s Change
94.55
Today|||52-Week Range
147.17
-2.24%
Year-to-Date
Novartis sBLA for CAR-T Therapy Kymriah Accepted by FDA
8:31am / Zacks.com - Paid Partner Content
David Rolfe Comments on Celgene
Jan 12 / GuruFocus News - Paid Partner Content
3 Top-Ranked Drug Stocks that are Broker Favorites
7:40am / Zacks.com - Paid Partner Content
Wedgewood Partners 4th Quarter 2017 Client Letter - The Great Bull Market of 2009-201...
Jan 12 / GuruFocus News - Paid Partner Content
Charter Trust Co Buys iShares Core MSCI Emerging Markets, The Home Depot Inc, iShares...
Jan 17 / GuruFocus News - Paid Partner Content
The Zacks Analyst Blog Highlights: Celgene, Amgen, Exelixis, Alexion and Vertex
Jan 12 / Zacks.com - Paid Partner Content
Dow Soars 322 Points to New Record, Exploding Past 26,000
Jan 17 / TheStreet.com - Paid Partner Content
Hikari Power Ltd Buys BHP Billiton PLC, Allergan PLC, Express Scripts Holding Co, Sel...
Jan 12 / GuruFocus News - Paid Partner Content
Juno's Stock High on Possible Acquisition
Jan 17 / GuruFocus News - Paid Partner Content
Lederer & Associates Investment Counsel Buys Naspers, The Madison Square Garden Co, C...
Jan 11 / GuruFocus News - Paid Partner Content
Reversal Offers Chance in 2 Small Biotechs
Jan 17 / TheStreet.com - Paid Partner Content
Can Biotech Keep Last Year's Momentum Alive in 2018?
Jan 11 / Zacks.com - Paid Partner Content
Stocks Rebound Despite Financial Sector Weakness
Jan 17 / TheStreet.com - Paid Partner Content
Lgt Capital Partners Ltd. Buys Kansas City Southern, T-Mobile US Inc, KeyCorp, Sells ...
Jan 11 / GuruFocus News - Paid Partner Content
Is Celgene (CELG) Looking to Take Over Juno Therapeutics?
Jan 17 / Zacks.com - Paid Partner Content
Key Takeaways from Pfizer & 3 Other Drug Stocks at Healthcare Conference
Jan 11 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Juno Surges on Acquisition Rumor, Concert Down on Patent News ...
Jan 17 / Zacks.com - Paid Partner Content
Big Pharma CEOs Speak About Impact of Tax Reform on M&A
Jan 11 / Zacks.com - Paid Partner Content
Bank of America, Goldman Sachs, Juno and Ford - 5 Things You Must Know
Jan 17 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: Celgene to Acquire Impact, J.P. Morgan Healthcare Conference i...
Jan 10 / Zacks.com - Paid Partner Content
Deal Buzz Sends Juno Shares Soaring
Jan 16 / TheStreet.com - Paid Partner Content
Celgene Provides 2017 Preliminary Results & 2018 View
Jan 09 / Zacks.com - Paid Partner Content
Skylands Capital, LLC Buys Verso Corp, SBA Communications Corp, Advanced Disposal Ser...
Jan 16 / GuruFocus News - Paid Partner Content
Celgene to Acquire Impact Biomedicines to Boost Pipeline
Jan 08 / Zacks.com - Paid Partner Content
Concert Pharmaceuticals Plunges on Patent Petition Setback
Jan 15 / Zacks.com - Paid Partner Content
Will J&J (JNJ) Continue to Tread Growth Path This Year?
Jan 05 / Zacks.com - Paid Partner Content
4 ETFs Set to Surge in Q4 Earnings
Jan 15 / Zacks.com - Paid Partner Content